Cambridge Investment Research Advisors »

Acurx Pharmaceuticals shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Acurx Pharmaceuticals (ACXP) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Acurx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acurx Pharmaceuticals held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acurx Pharmaceuticals by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $25k 10k 2.50

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corp Com (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Value Etf (VTV)

View all positions for Cambridge Investment Research Advisors

Top funds holding Acurx Pharmaceuticals

Vanguard Group
Prospect Financial Services
Advisor Group Holdings
Citadel Advisors
Susquehanna International
TD Waterhouse Canada
Nbc Securities
Tocqueville Asset Management
Simplex Trading
Patriot Financial Group Insurance Agency
Cambridge Investment Research Advisors
Semmax Financial Advisors
Cornerstone Planning Group
Cutler
Jpmorgan Chase & Co

View all funds holding Acurx Pharmaceuticals